Professional Documents
Culture Documents
FUND
PORTFOLIO
ALLOCATION
Group 3
Priyanshi Shah (J026)
Shashank Jain (G009)
Sidharth Sharma (G036)
Sonal Bajoriya (G043)
Utkarsh Bhargava (G052)
Portfolio Rebalancing Report
Present Portfolio Status
During the period (09-07-2021 to 22-07-2021), StableGrow fund grew by 1.32%. The highest return
could be seen for the stock Mastek.
The percentage returns along with the Portfolio value are as below:
Company % CMP on 09- CMP on 22- % Returns Value on 09- Value on 22-
Name Allocation 07-2021(in 07-2021(in 07-2021(in 07-2021(in
INR) INR) INR) INR)
Tata Power 8% 124.45 123.7 -0.60% 6,00,000 59,63,84.09
Polycab 7% 1946.15 1911.95 -1.76% 5,25,000 5,15,774.09
Greenpanel 7% 241.35 234.2 -2.96% 5,25,000 5,09,446.86
Tata Elexsi 8% 4295.4 4246.6 -1.14% 6,00,000 5,93,183.41
Kotak 9% 1720.05 1707.2 -0.75% 6,75,000 6,69,957.27
Mahindra
Bank
Praj 10% 362.45 363.65 0.33% 7,50,000 7,52,483.10
Industries
Mastek 8% 2193.95 2714.75 23.74% 6,75,000 8,35,231.55
Sun Pharma 8% 667.9 687.3 2.90% 6,00,000 6,17,427.76
SAIL 8% 125.05 126.15 0.88% 6,00,000 6,05,277.89
Deepak 8% 1940.75 1929.45 -0.58% 5,25,000 5,21,943.19
Nitrite
Escorts 10% 1200.2 1166.95 -2.77% 7,50,000 7,29,222.21
Bluedart 9% 5894 5701.8 -3.26% 6,75,000 6,52,988.63
Total 75,00,000 75,99,320.05
Portfolio
Value
After analysis of the current portfolio returns, we decided to sell complete stake in SunPharma and
Bluedart. Using the CANSLIM Approach, we incorporate 3 new stocks into the portfolio: Suven
Pharma, InfoEdge and Angle Broking. We have further changed the percentage allocations keeping
in mind the strategy of StableGrow fund. A transaction cost of 0.15% has also been deducted at each
leg of the transaction.
The rebalanced portfolio is as below: